Evaluation of Interleukin 18 in Chronic periodontitis

Not Applicable

• Conditions: Chronic periodontitis.; Chronic periodontitis

• Registration Number: IRCT201404133795N2
• Lead Sponsor: Ahvaz Jundishapour University of Medical Sciences and Health Services

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Inclusin criteria: patients with severe periodontitis; patients with moderate to severe periodontitis; subjects with periodontal healthy
Exclusion criteria: periodontal treatment or antibiotic therapy within the last 3 months; presence of any systemic disease (e.g.,diabetes mellitus, asthma); xerostomia or any other disease of the salivary glands; less than 20 teeth remaining; intake of any drug known to alter salivary rate levels (e.g., for sleeping disorders) or to be immunosuppressive; usage of partial or total prosthesis; pregnancy; lactation; acute infection; immunodeficiency; history of radio- or chemotherapy; and any conditions necessitating antibiotic premedication for dental appointment

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Interleukin 18. Timepoint: At the time of sampling. Method of measurement: ELISA kit.

Secondary Outcome Measures

Name	Time	Method
Interleukin 18. Timepoint: Six weeks after sampling. Method of measurement: ELISA kit.;Bleeding on probing. Timepoint: At the time of sampling. Method of measurement: By periodontal probe.